Article Listing - Monsanto Corn Under Attack by Superbug

Hib VACCINE LAUNCHED IN FRANCE

6 April 1992

Pasteur Vaccins has launched HIbest, a Hemophilus influenzae type B conjugate vaccine, in France. The product is suitable for...

BETA BLOCKERS AND DEPRESSION

6 April 1992

Commonly prescribed beta blockers used to treat conditions such as hypertension, angina and migraine do not cause depression, according to...

SANDOZ 1991 EARNINGS JUMP 15%

6 April 1992

Swiss pharmaceutical major Sandoz reported a 15% rise in net profit to 1.11 billion Swiss frances ($732.0 million) for 1991,...

PFIZER'S DIFLUCAN

6 April 1992

Prophylactic administration of Pfizer's Diflucan (fluconazole) to recipients of autologous bone marrow transplants reduces the incidence of both systemic and...

ALLELIX BIOPHARMA: DOUGLAS FROOM

6 April 1992

Douglas Froom has been appointed as vice president for business development at Allelelix Biopharmaceuticals Inc, of Canada.

GENZYME AND CYSTIC FIBROSIS

6 April 1992

Genzyme is to exercise its option to buy rights to Neozyme's cystic fibrosis protein replacement therapeutic program, under the terms...

BLOOD BANKING AND PLASMA PRODUCTS

6 April 1992

The world market for blood banking and plasma products was valued at $2.5 billion in 1990, and is expected to...

GLAXO FRANCE CHIEF QUITS

6 April 1992

Edwin Nathan, president of Glaxo France and of the group's Belgian and Luxembourg companies, has announced his departure from the...

ARAB PHARMA COOPERATION

6 April 1992

The executive board of the Union of Arab Druggists, meeting in Cairo, has established a new system of cooperation in...

GLOBAL MARKETS AND FACTORS FOR SUCCESS

6 April 1992

As the geographical borders between pharmaceutical markets begin to disappear, so do the differences among the critical success factors for...

Showing 94651-94660 of 95569 articles